Reddit Posts
I called $DRMA and $SMFL before the pop. Both tickers ran. Congrats who took the call. All out, now only in $OMH.
Microcaps trading ideas for next week; $DRMA, $OLB, $DSS, $AMLI
Thanks to the guys that pointed out $DRMA last week.
$DRMA up 10% AH. Once volume finds this it’ll soar. Only 600k float. CTB 300% only 10k shares left available to short.
$DRMA 10k short shares avail. 320% CTB 610k Float. Recently split also. FYI I called $SMFL earlier today before the pop. This could be next.
Feetr Data Dump: OCEA GETR DRMA CNSP MOBQ ALLR AUGX RCRT
$DRMA 6,500% turnover 55 million volume with 670k float…
Another Home Run Trade | DRMA Stock Major Buy Alert | $DRMA Stock Price Prediction & Analysis
DRMA - It’s jumping up in pre market?
DRMA - lowest float biotech...next squeeze? low float biotechs squeezing 1000%+...don't overthink it
possible squeeze candidates $REVB $DRMA $GMBL $MRKR $VERU $CYTO $OCGN
Feetr Data Dump: FRC BOXD PXMD PACW DRMA TRKA ZURA
💰💰💰Good morning! #premarket #watchlist 12/30 $PALI -old news+big volume(+96%), $TUEM -old news+big volume(+68%), $KALA -old news+legendary runner (+43%), $DRMA - no news+big volume(+90%)
Something new and not yet in the spotlight? Maybe DRMA..🚀
CREX is squeezing - SBFM and BRCC I think are most likely next
..Today the surprise could be SYTA...and maybe DRMA 🕰💣
Called out NSRN yesterday, calling out DRMA today
#premarket #watchlist 02/10 $IRNT - Agreement with a Gulf Cooperation Council Country, $IFBD- no news, $AREB -Closing of $10.5 Million Public Offering, $DRMA -no news , $GRAB - earnings... Also check afterhours runners and low float stocks in my app!
Looks like DRMA gonna have a little squeeze today
Mentions
No I have not I’ll look at it. I been watching DRMA and SAFX. Good swings in SAFX and DRMA looks ready for a break out. It’s been oversold and think DRMA is getting ready! We’ll see!
Well jimmy did DRMA fall off a cliff?
CtB on this is rising too. I like this. I like PAVS. And I'm keeping an eye still on DRMA. These 3 seem like the picks for next week.
https://preview.redd.it/k6i76w4mx2gg1.jpeg?width=1006&format=pjpg&auto=webp&s=9618974abdbf5155fe4edaa5c8947a9c99a620e2 $DRMA slowly but surely $SHPH popped some yesterday - more to come 👀
🍋 $DRMA - just posted SqueezeFinder screenshot. Ready to explode with momentum 🤞🏼 $TOVX - highest penny stock on squeezefinder and awaiting phase 3 results 💸 $NUKK- 52 wk low yesterday. Earnings 2/9
DRMA is waking up. 3,604.43% of the float shorted. 0 shares available CTB is 488 Volume is 20x
DRMA up 104% . Let’s keep it going
Hey guys, what do you think about DRMA. Is it showing potential?
Got in with DRMA premarket
DRMA is about to absolutely cook the shorts. DRMA CEO did an interview on YouTube about what the company is up to and how effective their product is. He also mentioned that DRMA has moved from FDA to OTC so that the product is easier to purchase without the need of a prescription.
CJMB top of SqueezeFinder rn 👀 discovery conference on 1/28 Followed by DRMA YYAI NFE 🍋🤷🏼♀️
DRMA for short squeeze? at 115% short float
My FinHealth score is solid for DRMA, so they don’t have too much debt. Is there another reason they might need to raise capital?
Scroll up! There’s a few! Also here’s one we’ll know by March or April! ATCH super cheap now ! If they pull off the bank merger and they get the platform they are working on up and running. Eventually they go boom. Even swing trading that crap on the 5-10% swings will double your money in a month or so! It’s strategy and no brains!🧠 lol! ASST. just finished their merger with SMLR. They will now own 12000 plus BTC! Incoming RS since merger just completed today! Wait for it! Everyone says RS no good! Hahaha! I think it’ll be a 20:1 split the available shares are going to drop from post merger of about a billion shares to 50 million. It’s going to pull back from all that are spooked in RS and then it’s going to slowly climb while it’s slowly climbing swing intraday every so may days on the swings of 5-10%. At least it has when it’s .95-1.05 on the daily/weekly. A few weeks of watching shorts buy and short that shit and making money on both side of the trade! You can double your money just on those swings! But if you can’t scroll: DRMA slow climb and supposedly going to pop with some volume! IBRX already moving get in premarket or after it drops on open. It may have more to run with the volume this week and calls that closed ITM today! But you do you! No guarantees and this is a casino NFA! ASST slow climb we’ll see where it is in another 6th the to a year!
IBRX. DRMA. I mean they have bumped up a little. But if they run they are going to 4X supposedly! lol!
IBRX. That’s supposedly the next big runner. Shit ton of options expired ITM today. Thinking a crap ton of naked calls. They’ll be able to cover but it already has had solid three days of running! After hours popped again! Possibly running some more next week! Go read up on it and make your decision. It’ll be a wild ride for sure! The question is are you regarded enough? A lot of people call these different tickets scams and garbage. Who the heck know if they’ll continue to run like PLTR or ASTS. Samsies I don’t pick that PLTR horse and look where that mutha is now! Cathy woods was confident on PLTR while it dumped look at that now! Her latest is DRTS! What will become of that who knows. Another strange candidate DRMA, go look at the short interest on that and the borrow rate and low float. Soon enough a run is going to be made on it, maybe…. lol. No one was taking about MLEC a few screeners caught it this week. I saw it on the NYSE LULD halts page and it ran for a hot second. Go look at the 1 minute on that this week! So there are so many and they are all a gamble unless you are in on the run! That’s the current trends say what you will. Microcap and penny stocks with low float so on and so forth with lock ups and low authorized shares with high short interest and CTB. It surely isn’t easy. But they are there!
As of yesterday night regsho lists DRCT DRMA RPGL WOK On threshold. https://www.nasdaqtrader.com/trader.aspx?id=regshothreshold
fuck it bought some DRMA
DRMA is #1 on the SqueezeFinder Watchlisr this morning 🙌
Quick regsho check https://www.nasdaqtrader.com/trader.aspx?id=regshothreshold From my radar we have on regsho as of yesterday: DRCT DRMA RPGL WOK
DRMA SKYQ OPTT and NFE all very high on SqueezeFinder chart
DRMA Leading the SqueezeFinder charts for its squeeze potential and ability. Gained CTB and momentum all day yesterday. Float less than a million. Worth taking a look https://preview.redd.it/goc5v6k1mobg1.jpeg?width=1170&format=pjpg&auto=webp&s=3f02bba44324fc2cb2c623550e07fc7b37b180f3
DRMA? Presentation Friday, and super small market cap
$DRMA 900k float , patent approved news out today , went from $2 to $80 last year
$DRMA? Anyone holding this share? It is going to launch its product in mid-June 2026. [Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments](https://finance.yahoo.com/news/dermata-therapeutics-announces-strategic-pivot-120000843.html)
Will DRMA receive compliance from the Nasdaq? May 9 is the deadline for DRMA to submit a plan for compliance.
No. Sold a little too early yesterday. I am bagging DRMA though.
Even if MIST was approved. I would bet it would go the DRMA route. Just pump and dump in minutes :/
If you were HODL onto DRMA you should wakeup very early tomorrow [https://www.stocktitan.net/news/DRMA/dermata-therapeutics-announces-exercise-of-warrants-for-6-2-million-uv0p8mmvw294.html](https://www.stocktitan.net/news/DRMA/dermata-therapeutics-announces-exercise-of-warrants-for-6-2-million-uv0p8mmvw294.html)
50% if it will be good or bad though which is why I sold it today for a small 10% which helped ease the burns of my giant fumble with DRMA that ticker was a omen
Is anyone thinking of holding DRMA overnight??
DRMA 45% loss, it's over for me. No capital left to trade for a few weeks
Great dip on DRMA. To pump AH or tomorrow PM for sure
DRMA another FOMO mistake. Naturally it has good analyst ratings, so it went all to hell. "The company does not hold much long-term debt and may be undervalued. The factor rank is based on the stock having low long term debt to equity ratio, low price to book value (relative to its industry), high return on equity, low price to sales ratio, and relatively high cash flow" So why the hell did it nosedive almost 40%? Total shit day.
I lost 1k in DRMA bro we both fucked
Wtf happened to DRMA lol
I'm so mad at myself. Why did I get into DRMA ughh
DRMA is truly worthless
The stocks I went into yesterday were pretty good, I FOMOd into one stock today DRMA and it's shit. Figured
buying DRMA on the dip $1.59 needs an FDA approval for acne which seems highly favorable considering trial results
Back to $1.30 and I'm in there like swimwear on DRMA
DRMA another soul snatcher
DRMA had news about the possible FDA approval in 6+ months. MIST is FDA approval/denial today. The real worry is denial.
DRMA definitely put me red but I’m happy I was disciplined ENOUGH to just cut my loss early even though I wasn’t disciplined enough to not stick my current rule of splitting my funds into 4ths for plays
Looking for second DRMA pump 😎
DRMA such a waste. Never should have fell for the Reddit hype. lmao
DRMA price action is making me worried for $MIST I’m not going to lieeeeee lol
well i made several 5% trades on DRMA this morning for a total of 10% profit/$260usd
Glad I hopped outta DRMA at break even personally 🤷
DRMA will explode at market open
If DRMA moons and I missed it I’m glad for yall.
Hopped on outta DRMA. Really hope it moons for y’all but I feel like this one is sketch with all of the news of warrants floating around here and Stocktwits. Will re-enter at 1.9 💪
Hope y’all didn’t get scared off! DRMA on the move
I got out of DRMA at break even btw. Didn't realise they had warrants ready to be executed
Mkt open will be fun for DRMA
I’m in DRMA at 2.09…the second I have an out I’m taking it lmao
Those who play DRMA will definitely get their share of DRAMA this morning. Here's hoping everyone finds their exit
In DRMA @ $1.94. Let’s see what she does.
All Volume is flying in DRMA. Its going to grab more attention and it’s definitely flying more today 🧨
DRMA - holding nicely, open market then we shall see the movement up/down etc.
DRMA could touch that $6 mark it was at less than a year ago… (NFA)
In DRMA at $2. Give it time to build
DRMA going to be huge today 🤑
Everyone needs to jump on DRMA before market opens it has higher PT 🔥🔥
Wow my order not filling on time really fucked me over with DRMA. Of course!!!
DRMA took a bit to fill so got in at 2.43 hopefully goes up lol
DRMA about to blow more 🚀🚀
DRMA is flying… $7 incoming?
DRMA - watch and scale in, it will be volatile
Crazy that DRMA got halted at 4% increase lol
DRMA halted on news to resume 830
DRMA will pullback after unhalt, wait before you go
DRMA came out of nowhere and stole MIST's spotlight. Good luck to both
So much attention on DRMA, really hope she shoots and not plummets at bell because of the spotlight
DRMA! Is the play of the day!
Whatever you're holding and not making money, DRMA is your chance! 4mil float! Point 3 - possible buyout as well! **Successful Phase 3 Results:** Meeting all primary endpoints strengthens the case for FDA approval. * **Potential Market Impact:** First once-weekly topical treatment for moderate-to-severe acne, which could improve patient compliance. * **Next Steps:** The second Phase 3 STAR-2 trial starts in 2H 2025, followed by an extension study. * **Partnership Opportunities:** Dermata is seeking commercialization partners, which could drive stock momentum.
https://preview.redd.it/5c50eklo48re1.jpeg?width=1170&format=pjpg&auto=webp&s=07a1a94650f209379da3a06b76b3c1823af2a6d8 DRMA
When is the DRMA halt supposed to be lifted?
DRMA will blast to the roof, 4mil float and topline result! 8.30 to load it!
Waiting for DRMA to not be halted
DRM, low float buy when unhalt ! # BREAKING: Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints **Thursday, 27****^(th)** **March at 8:00 am** *- XYNGARI™ achieved its primary endpoints, demonstrating highly statistically significant and clinically meaningful improvement in acne -* *- XYNGARI™ is the first once-weekly topical product candidate to demonstrate clinical benefit in a Phase 3 clinical trial for moderate-to-severe acne* \- *- Over 30 million acne patients seek treatment in the U.S. each year -* SAN DIEGO, March 26, 2025 /PRNewswire/ -- [Dermata Therapeutics, Inc.](https://c212.net/c/link/?t=0&l=en&o=4392681-1&h=1814492621&u=https%3A%2F%2Fwww.dermatarx.com%2F&a=Dermata+Therapeutics%2C+Inc.) (NASDAQ: DRMA, DRMAW)) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications, today announced positive topline results from the Company's first pivotal Phase 3 trial of XYNGARI™, a novel, once-weekly, topical product candidate for the treatment of moderate-to-severe acne. XYNGARI^(TM) also appeared to be safe and well tolerated by patients with minimal treatment related adverse events and no serious adverse events attributed to treatment. The XYNGARI™ Phase 3 **S**pongilla **T**reatment for **A**cne **R**esearch (STAR-1) trial met all three primary endpoints by achieving a statistically significant difference when compared with placebo after 12 weeks of once weekly treatments with XYNGARI™. "I believe having a once-weekly topical product with a strong efficacy and safety profile, like XYNGARI™, would be a great addition to a dermatologist's arsenal for treating acne," commented Dr. Sunil Dhawan, MD, FAAD, FACP, clinical investigator at the Center for Dermatology Clinical Research, Inc., a participating site in the STAR-1 trial. "All FDA approved topical acne products are required to be applied at least once or twice a day, which may reduce patient compliance, so I believe having a once-weekly topical acne product like XYNGARI™ could lead to improved patient compliance," concluded Dr. Dhawan. "We are incredibly excited about these Phase 3 clinical trial results for XYNGARI™, which we believe reinforce its potential as a unique acne treatment, distinct from any existing product on the market," said Gerry Proehl, Chairman, President, and Chief Executive Officer of Dermata. "The highly statistically significant efficacy data not only confirms the results of our Phase 2b acne study but also strengthens our confidence about the upcoming XYNGARI™ Phase 3 STAR-2 trial, set to launch in the second half of 2025. With these positive Phase 3 clinical trial results, we are eager to advance discussions with potential partners interested in securing future rights to XYNGARI™," Mr. Proehl added.BREAKING: Dermata's XYNGARI™ Phase 3 Trial Topline Data Meets All Primary Endpoints